Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Valvular heart disease 

Valvular heart disease
Chapter:
Valvular heart disease
Author(s):

Francesca Mantovani

DOI:
10.1093/med/9780198759935.003.0016

July 29, 2020: This chapter has been re-evaluated and remains up-to-date. No changes have been necessary.

Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 22 January 2022

Valvular heart disease is common, and any of the four valves of the heart can be affected, although left-sided valvular disease is far commoner than right-sided disease. Treatment depends on the valvular disease type and severity but, when severe and symptomatic, usually involves mechanical intervention. Asymptomatic patients without objective parameters suggesting high morbid or lethal risk are closely observed clinically, until surgical indications develop. Although often prescribed, no rigorous evidence supports pharmacological therapy in most chronic valve diseases, although drugs may be useful in acute valvular diseases or as a bridge to surgery in severely decompensated patients. Moreover, given the rising proportion of frail older people with symptomatic degenerative valve disease, in whom the risks of mechanical intervention are prohibitive, medical treatment could be the only option.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.